The concerned supplier is also directed to replace the affected batch and a Show Cause Notice is issued seeking an explanation and details of the corrective measures. Image used for representation only.
| Photo Credit: Getty Images/iStockphoto
Recall of certain batches of disposable syringes at All India Institute of Medical Sciences (AIIMS), New Delhi, was undertaken as a precautionary and patient-safety measure following reports of quality-related issues from user departments, said a source in the Union Health Ministry on Thursday (June 11, 2026).
The information comes following a report by The Hindu where the Ministry was urged to investigate the repeated recall of disposable syringe batches at the hospital and the possible implication for patient safety.
In a letter written to Union Health Minister J.P. Nadda on Wednesday (June 10, 2026), Rajya Sabha MP Haris Beeran said that in the past month two separate recall notices were issued within a span of three weeks for disposable 10 ml syringes with needles supplied by different manufacturers, citing quality-related complaints.
The source stated that the concerned batches were withdrawn from use immediately in accordance with established institutional protocols after complaints were received regarding product quality.
“The action was taken as part of a robust quality surveillance mechanism designed to ensure that any potential deficiency in medical consumables is identified and addressed at the earliest stage,” he said.
Structured system
He further said that AIIMS maintains a structured incident reporting and monitoring system for medical devices and consumables.
“Whenever any quality concern is reported, the information is communicated through prescribed channels and immediate action is initiated to identify, isolate and withdraw the affected material from all user areas,” said the source.
The concerned supplier is also directed to replace the affected batch and a Show Cause Notice is issued seeking an explanation and details of the corrective measures. The matter is subsequently examined in accordance with applicable rules, regulatory provisions and contractual conditions, and appropriate action is taken wherever warranted.
Published – June 11, 2026 11:22 pm IST
